Mark Heinen
CIK 1888531 · Chief Financial Officer · last filed 2025-05-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$39.1K
Companies
3
Total Filings
11
Lifetime Open-Market Net
$141.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SOAR | Chief Financial Officer | 192,963 | $0.20 | $39.1K | $0 | 1 | 2025-05-09 |
| Volato Group, Inc. (SOAR.WS) Delisted | Chief Financial Officer | 147,963 | $0.01 | $1.0K | $6.8K | 2 | 2024-06-11 |
| Better Therapeutics, Inc. (BTTX) Delisted | Chief Financial Officer | 142,003 | $0.04 | $6.3K | $135.1K | 8 | 2023-04-21 |
Recent Filings · Page 2 of 2
11 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-01 | Better Therapeutics, Inc. (BTTX) Delisted | Grant (A) | +6,667 | $0 | EDGAR |
Showing 11–11 of 11
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.